Effectiveness and persistence of vedolizumab in patients with Inflammatory bowel Disease: Results from the Belgian REal-LIfe study with VEdolizumab (Be-RELIVE)

Authors
Category Primary study
JournalJournal of Crohn's and Colitis
Year 2018
This article has no abstract
Epistemonikos ID: b495d5e5017ff331d3d10e52c5fe3bfc4a987b69
First added on: Feb 09, 2025